Search hospitals > Oklahoma > Oklahoma City
Oklahoma Medical Research Foundation
Claim this profileOklahoma City, Oklahoma 73104
Global Leader in Systemic Lupus Erythematosus
Global Leader in Lupus
Conducts research for Multiple Sclerosis
Conducts research for Coronary Artery Disease
Conducts research for Rheumatoid Arthritis
154 reported clinical trials
6 medical researchers
Summary
Oklahoma Medical Research Foundation is a medical facility located in Oklahoma City, Oklahoma. This center is recognized for care of Systemic Lupus Erythematosus, Lupus, Multiple Sclerosis, Coronary Artery Disease, Rheumatoid Arthritis and other specialties. Oklahoma Medical Research Foundation is involved with conducting 154 clinical trials across 114 conditions. There are 6 research doctors associated with this hospital, such as Gabriel Pardo, Cristina Arriens, MD, MSCS, Judith A. James, MD, PhD, and Christina Arriens, MD.Area of expertise
1Systemic Lupus Erythematosus
Global LeaderANA positive
anti-dsDNA positive
anti-Sm positive
2Lupus
Global LeaderANA positive
dsDNA positive
anti-dsDNA positive
Top PIs
Gabriel PardoOklahoma Medical Research Foundation5 years of reported clinical research
Studies Multiple Sclerosis
Studies Syndrome
9 reported clinical trials
17 drugs studied
Cristina Arriens, MD, MSCSOklahoma Medical Research Foundation6 years of reported clinical research
Studies Systemic Lupus Erythematosus
Studies Lupus
4 reported clinical trials
8 drugs studied
Judith A. James, MD, PhDOklahoma Medical Research Foundation: Arthritis and Clinical Immunology Research Program6 years of reported clinical research
Studies Systemic Lupus Erythematosus
Studies Lupus
2 reported clinical trials
5 drugs studied
Christina Arriens, MDOklahoma Medical Research Foundation1 year of reported clinical research
Studies Systemic Lupus Erythematosus
Studies Lupus
2 reported clinical trials
7 drugs studied
Clinical Trials running at Oklahoma Medical Research Foundation
Multiple Sclerosis
Lupus
Systemic Lupus Erythematosus
Shingles
Neuromyelitis Optica (NMO)
Nephritis
Lupus Nephritis
Ocrelizumab
for Multiple Sclerosis
This trial is testing if patients with early relapsing multiple sclerosis can stop taking Ocrelizumab after initial treatment without their disease getting worse. Ocrelizumab is a medication given through an IV that helps manage multiple sclerosis by reducing harmful immune cells. The study will monitor patients for new disease activity over several years.
Recruiting2 awards Phase 4
Frexalimab
for Multiple Sclerosis
This trial compares a new treatment, frexalimab, with an existing pill, teriflunomide, in adults aged 18-55 who have relapsing multiple sclerosis. The study aims to see if frexalimab can reduce the frequency of symptom relapses better than teriflunomide. Participants will be monitored over several years.
Recruiting1 award Phase 34 criteria
Frexalimab
for Multiple Sclerosis
The purpose of this randomized, double-blind, placebo-controlled, parallel group study is to determine the efficacy of frexalimab in delaying the disability progression and the safety up to approximately 51 months administration of study intervention compared to placebo in male and female participants with nrSPMS (aged 18 to 60 years at the time of enrollment). People diagnosed with nrSPMS are eligible for enrollment as long as they meet all the inclusion criteria and none of the exclusion criteria. Study details include: * This event-driven study will have variable duration ranging from approximately 27 to 51 months. * The study intervention duration will vary ranging from approximately 12 to 51 months. * The number of scheduled visits will be up to 27 (including 3 follow-up visits) with a visit frequency of every month for the first 6 months and then every 3 months.
Recruiting1 award Phase 36 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Oklahoma Medical Research Foundation?
Oklahoma Medical Research Foundation is a medical facility located in Oklahoma City, Oklahoma. This center is recognized for care of Systemic Lupus Erythematosus, Lupus, Multiple Sclerosis, Coronary Artery Disease, Rheumatoid Arthritis and other specialties. Oklahoma Medical Research Foundation is involved with conducting 154 clinical trials across 114 conditions. There are 6 research doctors associated with this hospital, such as Gabriel Pardo, Cristina Arriens, MD, MSCS, Judith A. James, MD, PhD, and Christina Arriens, MD.